A new study points to a particular antibody “signature” to predict the likelihood of lingering COVID-19 symptoms.
A significant proportion of people who contract COVID-19 — around one-third, according to most estimates — will go on to experience symptoms that can linger for months. Little is known about this post-acute COVID-19 syndrome (PACS), more commonly known as “long COVID,” but one group of researchers has discovered a simple blood test that, when combined with other factors, could help to predict who is most at risk. Read more in Inside Science.